Pets at Home puts recycling points in stores
Working with specialist recycler Enval, which has developed a microwave-induced pyrolysis process that recycles and recovers flexible, rigid and complex plastics, Pets at Home and its partners are establishing the first store take-back and recycling scheme specifically for pet food packaging.
DEFINIGEN ACHIEVES ISO 9001: (2015) CERTIFICATION
DefiniGEN, a provider of iPSC-derived products and disease modelling services, today announces that the company has earned ISO 9001: 2015 certification at its Cambridge UK facility.
Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical Co. Ltd.
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced an exciting partnership with Ono Pharmaceutical Co., Ltd., one of Japan’s largest pharmaceutical companies and a global leader in the field of R&D-orientated drug discovery.
Privitar Expands Executive Leadership Team with Appointments of Victoria Normark as Chief Technology Officer, Pat Walsh as Chief Marketing Officer, and Bill Ziske as SVP of Sales North America
Software and security industry veterans round out C-suite, align Privitar for next stage of innovation and growth
Qkine and Enantis sign a licensing deal to bring hyperstable FGF2-STAB® to the global stem cell community
Cambridge University spin-out, Qkine, and Enantis, a biotechnology spin-off company from Masaryk University, have concluded a licensing deal for Qkine to use Enantis’s patented FGF2-STAB® technology globally and develop new product-lines based on the unique biochemical properties of the protein.
Projects funded to turn wastes into jet fuel
Eight companies have been shortlisted to receive part of a £15m fund to set up waste-to-fuel plants for the aviation industry at a commercial scale.
Viagra can teach us a lot about treating rare diseases
Before it conquered the world, Viagra was a failing angina drug, and its potential was almost missed. Healx wants to ensure we don’t overlook other therapies
PharmEnable and LifeArc transcend vaccines to fight coronaviruses
AI drug discovery company PharmEnable and medical research charity LifeArc are collaborating to discover novel oral antiviral drugs with activity against coronaviruses.
Featurespace files two global patents for its fraud prevention technology
Featurespace has filed two global patents for its fraud prevention and anti-money laundering technology.
Arecor Therapeutics focused on Phase 1 trial of diabetes treatment AT278
A key focus for the second half of 2021 is the Phase I clinical trial for AT278 which, if successful, would add significantly to Arecor's diabetes franchise
Online fraudsters in the cross hairs of Featurespace sharpshooters
Life has just got tougher for online financial fraudsters after Cambridge-based Featurespace added two powerful weapons to its online defence armoury.
Paragraf™ nominated for Automotive Product of the Year Award
The Electronics Industry Awards, organised by Components in Electronics (CIE) publisher Datateam Business Media, is back for 2021 to celebrate the very best professionals, products, projects and companies from across the electronics sector.
Tripism's Adam Kerr on Trying to Build a Better Travel Intranet
First piloted six years ago to serve as the corporate travel intranet for Microsoft, Tripism since has expanded into a travel planning and engagement provider for a range of large companies.
PervasID pivots to overcome pandemic impact with Innovate UK EDGE help
A spin-out from Cambridge University has had support from Innovate UK EDGE to pivot into new markets with its patented inventory tracking system, after orders from the aviation spares industry collapsed during the COVID-19 crisis.
PervasID CEO & founder receives silver medal from the Royal Academy of Engineering
The CEO and founder of PervasID, the Cambridge-based battery-free RFID technology innovator used in healthcare, retail and manufacturing, has been recognised with a prestigious honour.
Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction
Monument Therapeutics, a stratified medicine company, today announced it has raised £2.625 million in seed funding to spin out of Cambridge Cognition Ltd and relocate to Alderley Park, Cheshire.
New chairman at BioTech Phico
Phico Therapeutics, a biotechnology company developing a new generation of antibiotics to overcome antibacterial resistance, has appointed a new chairman.
Consumer research shows strong demand for smart(er)phones that react to the world around them
Sound recognition will deliver a wave of new experiences on smartphones, and Audio Analytic's recent consumer research clearly shows a strong desire from users for these new AI-powered capabilities on their next device.
Porotech raises £3m for new generation of microdisplays
Unique approach enables brighter, sharper, more vivid displays for smart devices
Cambridge company is unlocking secrets of proteins after RSC Emerging Technologies Competition win
HexagonFab won the Enabling Technologies category 2018